Feb 01, 2024 / 10:30AM GMT
Presentation
Feb 01, 2024 / 10:30AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Christopher David O'Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Milano Furuta
Takeda Pharmaceutical Company Limited - President of Japan Pharma Business Unit
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Hiroyuki Matsubara
Nomura Securities Co. Ltd., Research Division - Research
Takeda Pharmaceutical Co Ltd
(NYSE:TAK)
$
17.09
-0.16 (-0.93%)
Market Cap: 54.58 Bil
Enterprise Value: 82.61 Bil
PE Ratio: 0
PB Ratio: 1.15
GF Score: 76/100 Q3 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Feb 01, 2024 / 10:30AM GMT
Release Date Price:
$14.38
(-1.51%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot